Grufity logo
Grufity logo

Latest Cormorant Asset Management, LP Stock Portfolio

$1.95Billion | No. of Holdings #51

Cormorant Asset Management, LP Performance

2026 Q2+10.10%
YTD+8.86%
2025+40.04%

About Cormorant Asset Management, LP and 13F Hedge Fund Stock Holdings

Cormorant Asset Management, LP is a hedge fund based in Boston, MA. On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Cormorant Asset Management, LP reported an equity portfolio of $2 Billions as of 30 Jun, 2026. <br><br> The top stock holdings of Cormorant Asset Management, LP are PRAX, , . The fund has invested 11% of it's portfolio in PRAXIS PRECISION MEDICINES I and 7% of portfolio in BRIDGEBIO ONCOLOGY THERAPEUT. <br><br> The fund managers got completely rid off CENTESSA PHARMACEUTICALS PLC (CNTA), MAZE THERAPEUTICS INC and ASCENDIS PHARMA A/S (ASND) stocks. They significantly reduced their stock positions in ARCUTIS BIOTHERAPEUTICS INC (ARQT), INSMED INC (INSM) and STRUCTURE THERAPEUTICS INC. Cormorant Asset Management, LP opened new stock positions in PARABILIS MEDICINES INC, CLIMB BIO INC (ELYM) and SPYRE THERAPEUTICS INC (AGLE). The fund showed a lot of confidence in some stocks as they added substantially to FAETH THERAPEUTICS INC (SNSE), BIOHAVEN LTD and ERASCA INC (ERAS).
Cormorant Asset Management, LP Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$1.95Billion
  as of Aug 14, 2026

Cormorant Asset Management, LP Annual Return Estimates Vs S&P 500

Our best estimate is that Cormorant Asset Management, LP made a return of 10.1% in the last quarter. In trailing 12 months, it's portfolio return was 84.2%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
parabilis medicines inc126,329,000
climb bio inc27,462,200
spyre therapeutics inc19,975,500
definium therapeutics inc18,816,000
ascendis pharma a/s13,336,000
kailera therapeutics inc12,116,500
enliven therapeutics inc7,612,500
ibio inc6,247,500
New stocks bought by Cormorant Asset Management, LP

Additions

Ticker% Inc.
faeth therapeutics inc235
biohaven ltd48.3
adlai nortye ltd37.28
erasca inc3.45
Additions to existing portfolio by Cormorant Asset Management, LP

Reductions

Ticker% Reduced
arcutis biotherapeutics inc-61.11
insmed inc-60.53
structure therapeutics inc-57.14
tarsus pharmaceuticals inc-55.56
mbx biosciences inc-50.89
arrowhead pharmaceuticals in-50.00
cogent biosciences inc-50.00
crinetics pharmaceuticals in-50.00
Cormorant Asset Management, LP reduced stake in above stock

Sold off

Ticker$ Sold
zura bio ltd-8,627,500
centessa pharmaceuticals plc-41,706,000
maze therapeutics inc-22,387,500
context therapeutics inc-1,387,420
monte rosa therapeutics inc-6,580,000
rallybio corp-3,588,000
terns pharmaceuticals inc-15,816,000
ascendis pharma a/s-21,729,400
Cormorant Asset Management, LP got rid off the above stocks

Sector Distribution

Cormorant Asset Management, LP has about 54.9% of it's holdings in Others sector.

  • Others
  • Healthcare
Sector%
Others54.9
Healthcare45.1

Market Cap. Distribution

Cormorant Asset Management, LP has about 3.6% of it's portfolio invested in the large-cap and mega-cap stocks.

  • UNALLOCATED
  • MID-CAP
  • SMALL-CAP
  • LARGE-CAP
  • MICRO-CAP
Category%
UNALLOCATED54.9
MID-CAP26.3
SMALL-CAP12
LARGE-CAP3.6
MICRO-CAP2.9

Stocks belong to which Index?

About 24.5% of the stocks held by Cormorant Asset Management, LP either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
Index%
Others75.5
RUSSELL 200024.5
Top 5 Winners (%)%
oruka therapeutics inc
94.0 %
mbx biosciences inc
63.3 %
biohaven ltd
56.5 %
adlai nortye ltd
52.5 %
TNGX
tango therapeutics inc
47.3 %
Top 5 Winners ($)$
rapport therapeutics inc
29.1 M
EWTX
edgewise therapeutics inc
26.3 M
oruka therapeutics inc
24.6 M
alumis inc
22.1 M
mbx biosciences inc
21.2 M
Top 5 Losers (%)%
SNSE
faeth therapeutics inc
-67.7 %
INSM
insmed inc
-24.3 %
bridgebio oncology therapeut
-14.9 %
OLMA
olema pharmaceuticals inc
-12.5 %
TARS
tarsus pharmaceuticals inc
-7.4 %
Top 5 Losers ($)$
bridgebio oncology therapeut
-23.8 M
SNSE
faeth therapeutics inc
-16.1 M
INSM
insmed inc
-7.5 M
OLMA
olema pharmaceuticals inc
-7.3 M
DRUG
bright minds biosciences inc
-2.7 M

Cormorant Asset Management, LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Cormorant Asset Management, LP

Cormorant Asset Management, LP has 51 stocks in it's portfolio. About 59.2% of the portfolio is in top 10 stocks. proved to be the most loss making stock for the portfolio. was the most profitable stock for Cormorant Asset Management, LP last quarter.

$1.95BTotal Value
59.00Positions
14 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of Cormorant Asset Management, LP, last reported on 14 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
ASND
Ascendis Pharma A/S

Ascendis Pharma A/S

ASND
Cormorant Asset Management, LP's holding in Ascendis Pharma A/S over time
0%0.00
$0.00
0%
decreased 100 percentsold off
DRUG
Bright Minds Biosciences Inc

Bright Minds Biosciences Inc

DRUG
Cormorant Asset Management, LP's holding in Bright Minds Biosciences Inc over time
3.24%900,000
$63.18M
3.24%
decreased 15.04 percentreduced